EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluating the Biochemical and Haematological Safety of the Histoplasma capsulatum var. farciminosum ‘8ZH’ Vaccine in Foals

Sabira E Alpysbayeva iD, Akbope A Abdykalyk iD, Kali Tileukhanov iD, Azamat R Abdimukhtar iD, Alinur T Toleukhan iD, Makhpal K Sarmykova iD, Aktoty M Anarbekova iD, Yeraly A Shayakhmetov iD, Nazym S Syrym iD, Sergazy Sh Nurabaev iD, Bolat A Yespembetov iD

Veterinary Medicine and Science · 2026

DOI: 10.1002/vms3.70764 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Veterinary Medicine and Science, 2026. Verfasst von Sabira E Alpysbayeva und 10 weiteren Autor:innen. Beteiligte Einrichtung: Research Institute for Biological Safety Problems, National Holding "QazBioPharm, Otar, Kazakhstan. Hauptthemen laut MEDLINE: Horse Diseases, Histoplasma, Fungal Vaccines, Histoplasmosis. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Institute for Biological Safety Problems, under the national holding "QazBioPharm", Kazakhstan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Epizootic lymphangitis (EEL), caused by Histoplasma capsulatum var. farciminosum (HCF), is a neglected equine fungal disease lacking effective vaccines. The newly developed inactivated ‘8ZH’ vaccine requires safety validation in the target species.

Objectives

To evaluate the biochemical, haematological and clinical safety of the inactivated HCF ‘8ZH’ vaccine in foals.

Methods

A controlled, single‐blinded study was conducted on 30 clinically healthy foals (4–6 months), randomized into vaccinated (n = 15) and control (n = 15) groups. Vaccinated animals received a 5 mL intramuscular dose (10 mg antigen, MONTANIDE GEL 01 PR adjuvant) on Day 0 and a booster on Day 21. Clinical observations (temperature, appetite, behaviour, injection site) were recorded daily. Blood was collected at baseline and on Days 7, 14, 21, 35 and 42 for biochemical, haematological and acute‐phase protein analysis. Data were analysed using repeated measures ANOVA.

Results

No severe or adverse reactions were observed. Mild, transient injection‐site swelling (< 4 cm) occurred in three vaccinated foals and resolved spontaneously. All animals maintained normal temperature and appetite. AST showed a transient increase on Day 14 ( p = 0.04); WBC also rose ( p = 0.03), indicating a typical immune response. Other parameters, including ALT, GGT, creatinine, total bilirubin and acute‐phase proteins (SAA, fibrinogen, haptoglobin), remained within physiological limits. No statistically significant long‐term deviations or toxic effects were noted.

Conclusions

The inactivated HCF ‘8ZH’ vaccine demonstrated a favourable safety profile in foals. These results support its continued development for use in EEL prevention programs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Horse DiseasesHistoplasmaFungal VaccinesHistoplasmosisAnimalsHorsesMaleVaccines, InactivatedFemaleVaccinationSingle-Blind Method

Stichwörter der Autor:innen

biochemical markersbiochemical parametersepizootic lymphangitisequine vaccinefoalshistoplasma capsulatum var. farciminosumhistoplasma farciminosumvaccine safety

Substanzen

Fungal VaccinesVaccines, Inactivated

Autor:innen und Institutionen

  • Research Institute for Biological Safety Problems, National Holding "QazBioPharm, Otar, Kazakhstan.
  • Al-Farabi Kazakh National University, Almaty, Kazakhstan.

ORCID-Profile: Sabira E Alpysbayeva, Akbope A Abdykalyk, Kali Tileukhanov, Azamat R Abdimukhtar, Alinur T Toleukhan, Makhpal K Sarmykova, Aktoty M Anarbekova, Yeraly A Shayakhmetov, Nazym S Syrym, Sergazy Sh Nurabaev, Bolat A Yespembetov

Förderung

  • Research Institute for Biological Safety Problems, under the national holding "QazBioPharm", Kazakhstan

Zitieren

APA

Alpysbayeva, S. E., Abdykalyk, A. A., Tileukhanov, K., Abdimukhtar, A. R., Toleukhan, A. T., Sarmykova, M. K., Anarbekova, A. M., Shayakhmetov, Y. A., Syrym, N. S., Nurabaev, S. S., & Yespembetov, B. A. (2026). Evaluating the Biochemical and Haematological Safety of the Histoplasma capsulatum var. farciminosum ‘8ZH’ Vaccine in Foals. Veterinary Medicine and Science. https://doi.org/10.1002/vms3.70764

Vancouver

Alpysbayeva SE, Abdykalyk AA, Tileukhanov K, Abdimukhtar AR, Toleukhan AT, Sarmykova MK, et al. Evaluating the Biochemical and Haematological Safety of the Histoplasma capsulatum var. farciminosum ‘8ZH’ Vaccine in Foals. Veterinary Medicine and Science. 2026. doi:10.1002/vms3.70764

BibTeX
@article{Alpysbayeva2026,
  author = {Alpysbayeva, Sabira E and Abdykalyk, Akbope A and Tileukhanov, Kali and Abdimukhtar, Azamat R and Toleukhan, Alinur T and Sarmykova, Makhpal K and Anarbekova, Aktoty M and Shayakhmetov, Yeraly A and Syrym, Nazym S and Nurabaev, Sergazy Sh and Yespembetov, Bolat A},
  title = {Evaluating the Biochemical and Haematological Safety of the Histoplasma capsulatum var. farciminosum ‘8ZH’ Vaccine in Foals},
  journal = {Veterinary Medicine and Science},
  year = {2026},
  doi = {10.1002/vms3.70764}
}
Kostenlos starten →